Page 298 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 298

254         SEcTIoN II    Pharmacology  ` PHARMACOLOGY—MISCELLANEOUS





                Drug names (continued)
                ENdING               CATEGORY                                  EXAMPLE
                Other
                -dronate             Bisphosphonate                            Alendronate
                -prazole             Proton pump inhibitor                     Omeprazole

                -prost               Prostaglandin analog                      Latanoprost
                -sentan              Endothelin receptor antagonist            Bosentan
                -tidine              H2-antagonist                             Cimetidine
                -vaptan              ADH antagonist                            Tolvaptan



               Biologic agents
                ENdING               CATEGORY                                  EXAMPLE
                Monoclonal antibodies (-mab)—target overexpressed cell surface receptors
                -ximab               Chimeric human-mouse monoclonal antibody  Rituximab
                -zumab               Humanized mouse monoclonal antibody       Bevacizumab
                -umab                Human monoclonal antibody                 Denosumab
                Small molecule inhibitors (-ib)—target intracellular molecules

                -tinib               Tyrosine kinase inhibitor                 Imatinib
                -zomib               Proteasome inhibitor                      Bortezomib
                -ciclib              Cyclin-dependent kinase inhibitor         Palbociclib
                Receptor fusion proteins (-cept)
                -cept                TNF-α antagonist                          Etanercept
                Interleukin receptor modulators (-kin)—agonists and antagonists of interleukin receptors
                -leukin              IL-2 agonist/analog                       Aldesleukin
                -kinra               Interleukin receptor antagonist           Anakinra









































          FAS1_2019_05-Pharmacology.indd   254                                                                          11/7/19   4:08 PM
   293   294   295   296   297   298   299   300   301   302   303